Simple, Visual, Point-of-Care SARS-CoV-2 Detection Incorporating Recombinase Polymerase Amplification and Target DNA–Protein Crosslinking Enhanced Chemiluminescence
Biosensors · 2024
DOI: 10.3390/bios14030135 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors, 2024. Verfasst von Hui Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Chemical Oncogenomics, Institute of Biomedical and Health Engineering, Shenzhen International Graduate School, Tsinghua Unive…. Hauptthemen laut MEDLINE: Recombinases, COVID-19. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, Synthetic Biology Research, Shenzhen International Graduate School, State Key Laboratory of Chemical Oncogenomics.
Abstract (Originalsprache)
The ongoing COVID-19 pandemic, driven by persistent SARS-CoV-2 transmission, threatens human health worldwide, underscoring the urgent need for an efficient, low-cost, rapid SARS-CoV-2 detection method. Herein, we developed a point-of-care SARS-CoV-2 detection method incorporating recombinase polymerase amplification (RPA) and DNA–protein crosslinking chemiluminescence (DPCL) (RPADPCL). RPADPCL involves the crosslinking of biotinylated double-stranded RPA DNA products with horseradish peroxidase (HRP)-labeled streptavidin (SA-HRP). Modified products are captured using SA-labeled magnetic beads, and then analyzed using a chemiluminescence detector and smartphone after the addition of a chemiluminescent substrate. Under optimal conditions, the RPADPCL limit of detection (LOD) was observed to be 6 copies (within the linear detection range of 1–300 copies) for a plasmid containing the SARS-CoV-2 N gene and 15 copies (within the linear range of 10–500 copies) for in vitro transcribed (IVT) SARS-CoV-2 RNA. The proposed method is convenient, specific, visually intuitive, easy to use, and does not require external excitation. The effective RPADPCL detection of SARS-CoV-2 in complex matrix systems was verified by testing simulated clinical samples containing 10% human saliva or a virus transfer medium (VTM) spiked with a plasmid containing a SARS-CoV-2 N gene sequence or SARS-CoV-2 IVT RNA. Consequently, this method has great potential for detecting targets in clinical samples.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Chemical Oncogenomics, Institute of Biomedical and Health Engineering, Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, China.
- Department of Chemistry, Tsinghua University, Beijing 100084, China.
- School of Food and Drug, Shenzhen Polytechnic University, Shenzhen 518055, China.
Förderung
- National Key R&D Program of China, Synthetic Biology Research
- Shenzhen International Graduate School, State Key Laboratory of Chemical Oncogenomics
Zitieren
APA
Chen, H., Zhuang, Z., Xu, N., Feng, Y., Fang, K., Tan, C., & Tan, Y. (2024). Simple, Visual, Point-of-Care SARS-CoV-2 Detection Incorporating Recombinase Polymerase Amplification and Target DNA–Protein Crosslinking Enhanced Chemiluminescence. Biosensors. https://doi.org/10.3390/bios14030135
Vancouver
Chen H, Zhuang Z, Xu N, Feng Y, Fang K, Tan C, et al. Simple, Visual, Point-of-Care SARS-CoV-2 Detection Incorporating Recombinase Polymerase Amplification and Target DNA–Protein Crosslinking Enhanced Chemiluminescence. Biosensors. 2024. doi:10.3390/bios14030135
BibTeX
@article{Chen2024,
author = {Chen, Hui and Zhuang, Zhiyuan and Xu, Naihan and Feng, Ying and Fang, Kaixin and Tan, Chunyan and Tan, Ying},
title = {Simple, Visual, Point-of-Care SARS-CoV-2 Detection Incorporating Recombinase Polymerase Amplification and Target DNA–Protein Crosslinking Enhanced Chemiluminescence},
journal = {Biosensors},
year = {2024},
doi = {10.3390/bios14030135}
}
EUVIMED